Vincent Capponi - May 23, 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
President and COO
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Vincent Capponi
Stock symbol
CTSO
Transactions as of
May 23, 2022
Transactions value $
$10,164
Form type
4
Date filed
5/25/2022, 04:31 PM
Next filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Purchase $3.21K +1.57K +0.36% $2.04 435K May 23, 2022 Direct
transaction CTSO Common Stock Purchase $605 +299 +0.07% $2.03 435K May 23, 2022 Direct
transaction CTSO Common Stock Purchase $6.35K +3.13K +0.72% $2.03 439K May 23, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock, par value $0.001 per share (the "Common Stock") upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 10,100 RSUs granted on March 15, 2018, (b) 17,900 RSUs granted on February 24, 2017, (c) 54,000 RSUs granted on June 7, 2016 and (d) 125,000 RSUs granted on April 8, 2015;
F2 (continued from footnote 1) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date) and will settle into Common Stock upon vesting: 20,739 RSUs granted on April 12, 2021 and unvested on the date hereof; and
F3 (continued from footnote 2) (iii) 210,806 shares of Common Stock owned by the reporting person, inclusive of the shares purchased on May 23, 2022 and reported on this Form 4.